J. Lipid Res. Please sign the JLR Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

A more recent version of this article appeared on March 1, 2007

Papers In Press, published online ahead of print November 26, 2006
J. Lipid Res., doi:10.1194/jlr.M600404-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M600404-JLR200v1
48/3/665    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, W.
Right arrow Articles by Nes, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, W.
Right arrow Articles by Nes, W. D.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on September 12, 2006
Revised on October 23, 2006
Accepted on November 25, 2006

Cholesterol import fails to prevent catalyst-based inhibition of ergosterol synthesis and cell proliferation of Trypanosoma brucei

Wenxu Zhou, George A. M. Cross, and W. David Nes

Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409

Corresponding Author: wdavid.nes{at}ttu.edu

Trypanosoma brucei (TB) cultured in rat blood, bovine serum or lipid-depleted serum generated distinct differences in cholesterol availability. Whereas cell proliferation of the parasite was relatively unaffected by cholesterol availability, the ratios of cellular ergostenols to cholesterol varied from close to unity to three orders of magnitude different with cholesterol the major sterol (> 99%) of bloodstream form cells. In the procyclic form cultured with lipid-depleted serum, 15 sterols at 52 fg/cell were identified by GC-MS. The structure of these sterols reveal a non-conventional ergosterol pathway consistent with the novel product diversity catalyzed by the recently cloned sterol methyltransferase (SMT). A potent transition state analog of the TB SMT C24-alkylation reaction, 25-azalanosterol [Ki 39 nM], was found to inhibit the growth of the procyclic and bloodstream forms at an IC50 of ca. 1 µM. This previously unrecognized catalyst-specific inhibition of cell growth was unmasked further using 25-azalanosterol-treated procyclic form which, compared to control cultures, causes a change in cellular sterol content from ergostenols to cholesterol. However, growth of the blood stream form disrupted by 25-azalanosterol is not rescued by cholesterol absorption from the host, suggesting an essential role for ergosterol (24-methyl sterol) in cell proliferation and that the SMT can be a new enzyme target for drug design.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Cell Sci.Home page
A. Fridberg, C. L. Olson, E. S. Nakayasu, K. M. Tyler, I. C. Almeida, and D. M. Engman
Sphingolipid synthesis is necessary for kinetoplast segregation and cytokinesis in Trypanosoma brucei
J. Cell Sci., February 15, 2008; 121(4): 522 - 535.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.